146 related articles for article (PubMed ID: 15671934)
21. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
[TBL] [Abstract][Full Text] [Related]
22. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
Ford AC
Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
[No Abstract] [Full Text] [Related]
25. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
Yamamoto T; Umegae S; Matsumoto K
Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
Ardizzone S; Bollani S; Manzionna G; Colombo E; Maconi G; Imbesi V; Bianchi Porro G
Ann Ital Chir; 2003; 74(6):621-5. PubMed ID: 15206802
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
Reinisch W; Stange EF;
Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
[No Abstract] [Full Text] [Related]
28. Treatment of Crohn's disease with cannabis: an observational study.
Naftali T; Lev LB; Yablecovitch D; Half E; Konikoff FM
Isr Med Assoc J; 2011 Aug; 13(8):455-8. PubMed ID: 21910367
[TBL] [Abstract][Full Text] [Related]
29. [Long term evolution of corticodependant and corticoresistant Crohn's disease patients treated by azzathioprine].
Karoui S; Hamrouni A; Bibani N; Serghini M; Boubaker J; Filali A
Tunis Med; 2011 Jul; 89(7):610-5. PubMed ID: 21780035
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Crohn's disease].
Beglinger Ch
Ther Umsch; 2003 Mar; 60(3):159-63. PubMed ID: 12693319
[TBL] [Abstract][Full Text] [Related]
31. Crohn's disease recurrence after total proctocolectomy with definitive ileostomy.
Amiot A; Gornet JM; Baudry C; Munoz-Bongrand N; Auger M; Simon M; Allez M; Cattan P; Sarfati E; Lémann M
Dig Liver Dis; 2011 Sep; 43(9):698-702. PubMed ID: 21474398
[TBL] [Abstract][Full Text] [Related]
32. Methotrexate for induction of remission in refractory Crohn's disease.
McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
[TBL] [Abstract][Full Text] [Related]
33. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G
Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028
[TBL] [Abstract][Full Text] [Related]
34. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
35. [Drug treatment of Crohn's disease].
van Deventer SJ; Tytgat GN
Ned Tijdschr Geneeskd; 1998 May; 142(21):1191-5. PubMed ID: 9627451
[TBL] [Abstract][Full Text] [Related]
36. [Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].
Domènech E; Scala L; Bernal I; García-Planella E; Casalots A; Piñol M; Esteve-Comas M; Cabré E; Boix J; Gassull MA
Gastroenterol Hepatol; 2004 Dec; 27(10):563-7. PubMed ID: 15574279
[TBL] [Abstract][Full Text] [Related]
37. Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn's disease. A study performed using the Lémann Index.
Bodini G; Giannini EG; De Maria C; Dulbecco P; Furnari M; Marabotto E; Savarino V; Savarino E
Dig Liver Dis; 2017 Feb; 49(2):175-180. PubMed ID: 27864028
[TBL] [Abstract][Full Text] [Related]
38. Thromboembolism as an important complication of inflammatory bowel disease.
Bollen L; Vande Casteele N; Ballet V; van Assche G; Ferrante M; Vermeire S; Gils A
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):1-7. PubMed ID: 26513610
[TBL] [Abstract][Full Text] [Related]
39. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
40. Maintenance of symptomatic remission in patients with Crohn's disease.
Stark ME; Tremaine WJ
Mayo Clin Proc; 1993 Dec; 68(12):1183-90. PubMed ID: 7902474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
